JAMP LEVOFLOXACIN DIN 02508478
Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE)
Available to quote
Health Canada record
| Active ingredient(s) | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01MA12 LEVOFLOXACIN |
| Original market date | 22-Jul-2024 |
| Current status date | 22-Jul-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02284715 | APO-LEVOFLOXACIN | APOTEX INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Marketed |
| 02325942 | APO-LEVOFLOXACIN | APOTEX INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Marketed |
| 02284707 | APO-LEVOFLOXACIN | APOTEX INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Marketed |
| 02508443 | JAMP LEVOFLOXACIN | JAMP PHARMA CORPORATION | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Marketed |
| 02508451 | JAMP LEVOFLOXACIN | JAMP PHARMA CORPORATION | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Marketed |
| 02565501 | PRO-LEVOFLOXACIN | PRO DOC LIMITEE | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Approved |
| 02415879 | PRO-LEVOFLOXACIN | PRO DOC LIMITEE | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Marketed |
| 02565498 | PRO-LEVOFLOXACIN | PRO DOC LIMITEE | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Approved |
| 02442302 | QUINSAIR | CHIESI FARMACEUTICI S.P.A. | Solution | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 240 MG | Marketed |
| 02298635 | SANDOZ LEVOFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Marketed |
| 02298651 | SANDOZ LEVOFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Marketed |
| 02298643 | SANDOZ LEVOFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Marketed |
| 02315432 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Marketed |
| 02315424 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Marketed |
| 02315440 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Marketed |
| 02430592 | AURO-LEVOFLOXACIN | AURO PHARMA INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Dormant |
| 02430606 | AURO-LEVOFLOXACIN | AURO PHARMA INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Dormant |
| 02430614 | AURO-LEVOFLOXACIN | AURO PHARMA INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Dormant |
| 02306735 | DOM-LEVOFLOXACIN | DOMINION PHARMACAL | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Pre Market |
| 02286920 | DOM-LEVOFLOXACIN | DOMINION PHARMACAL | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Pre Market |
| 02286939 | DOM-LEVOFLOXACIN | DOMINION PHARMACAL | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Pre Market |
| 02343940 | LEVOFLOXACIN | COBALT PHARMACEUTICALS COMPANY | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Pre Market |
| 02343967 | LEVOFLOXACIN | COBALT PHARMACEUTICALS COMPANY | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Pre Market |
| 02343959 | LEVOFLOXACIN | COBALT PHARMACEUTICALS COMPANY | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Pre Market |
| 02297825 | LEVOFLOXACIN INJECTION | TEVA CANADA LIMITED | Solution | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 5 MG | Cancelled Pre Market |
| 02505797 | MINT-LEVOFLOXACIN | MINT PHARMACEUTICALS INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Post Market |
| 02505819 | MINT-LEVOFLOXACIN | MINT PHARMACEUTICALS INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Post Market |
| 02505800 | MINT-LEVOFLOXACIN | MINT PHARMACEUTICALS INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Post Market |
| 02313987 | MYLAN-LEVOFLOXACIN | MYLAN PHARMACEUTICALS ULC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Post Market |
| 02313979 | MYLAN-LEVOFLOXACIN | MYLAN PHARMACEUTICALS ULC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Post Market |
| 02286947 | PHL-LEVOFLOXACIN | PHARMEL INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Pre Market |
| 02306891 | PHL-LEVOFLOXACIN | PHARMEL INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Pre Market |
| 02286955 | PHL-LEVOFLOXACIN | PHARMEL INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Pre Market |
| 02284685 | PMS-LEVOFLOXACIN | PHARMASCIENCE INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Post Market |
| 02284677 | PMS-LEVOFLOXACIN | PHARMASCIENCE INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Post Market |
| 02305585 | PMS-LEVOFLOXACIN | PHARMASCIENCE INC | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Post Market |
| 02492733 | RIVA-LEVOFLOXACIN | LABORATOIRE RIVA INC. | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Dormant |
| 02492741 | RIVA-LEVOFLOXACIN | LABORATOIRE RIVA INC. | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Dormant |
| 02492725 | RIVA-LEVOFLOXACIN | LABORATOIRE RIVA INC. | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Dormant |
| 02248263 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG | Cancelled Post Market |
| 02248262 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG | Cancelled Post Market |
| 02285649 | TEVA-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24671 | 2020-11-24 | Abbreviated New Drug Submission (ANDS) |